Conclusively, the superior tumor inhibitory effect of E8-PE8 immunotoxin on CDH17-positive PDX model supports that E8-PE38 immunotoxin holds great potential for further clinical development, and its high effectiveness and low systemic toxicity also prove that CDH17 is a targetable molecule for gastric cancer imaging and therapy. Here, CDH17 is linked to gastric cancer.